Krystina L. HoKrystina L.Ho
Of Counsel, Intellectual Property
Krystina L. Ho is an of counsel in the Litigation Department and is based in the firm’s New York office. Her practice focuses on complex patent litigation, primarily in the fields of pharmaceuticals and biotechnology.
Dr. Ho received her law degree from Columbia Law School, where she was a Harlan Fiske Stone Scholar and served as the editor-in-chief of Columbia Law Review. She obtained her Ph.D. from the University of British Columbia in Biochemistry and Molecular Biology in 2013 and graduated with a B.M.Sc. in Biochemistry from the University of Western Ontario in 2007. Dr. Ho is admitted to practice law in New York and before the U.S. Court of Appeals for the Federal Circuit.
Columbia Law School, J.D., 2016
University of British Columbia, Ph.D., 2013
University of Western Ontario, BMSc, 2007
Boehringer Ingelheim in connection with BPCIA litigation relating to its biosimilar version of Humira®, which ultimately settled on favorable terms.
Daiichi Sankyo Company in a hotly contested, multi-billion-dollar breach of contract and intellectual property dispute relating to antibody-drug conjugate (ADC) technology for the treatment of various cancers. The team secured a complete arbitration victory, with the tribunal dismissing all claims as both substantively meritless and time-barred. The case was reported to be one of the largest ever handled by the International Centre for Dispute Resolution (ICDR).